Related Experiment Video
Updated: Mar 2, 2026
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Paper-Based Diagnostics: Rethinking Conventional Sickle Cell Screening to Improve Access to High-Quality Health Care
Insights
Sickle cell disease (SCD) is a serious genetic blood disorder. Early diagnosis and comprehensive care through newborn screening programs significantly improve survival rates, allowing children to live into adulthood.
Area of Science:
- Genetics
- Hematology
- Pediatrics
Background:
- Sickle cell disease (SCD) is a prevalent genetic blood disorder affecting hemoglobin.
- Untreated SCD leads to high mortality rates in children under five.
- Effective diagnostics and treatments for SCD exist.
Purpose of the Study:
- To highlight the critical importance of early diagnosis and treatment for sickle cell disease.
- To underscore the success of universal newborn screening programs in managing SCD.
Main Methods:
- Review of existing diagnostic methods for sickle cell disease.
- Analysis of treatment regimens and their efficacy.
- Evaluation of outcomes from newborn screening programs.
Main Results:
- Early diagnosis and comprehensive care dramatically improve survival rates for children with SCD.
- Universal newborn screening programs demonstrate significant success in North America and Europe.
- Children diagnosed early and treated effectively can live well into adulthood.
Conclusions:
- Universal newborn screening for sickle cell disease is a highly effective public health strategy.
- Timely intervention is crucial for improving long-term outcomes in individuals with SCD.
- Continued implementation and expansion of screening programs are vital for global SCD management.
Abstract:
Every year, hundreds of thousands of children worldwide are born with sickle cell disease, a genetic disorder that impacts the hemoglobin molecules in blood. If left undiagnosed and untreated, most affected children will die before reaching the age of five. However, highly accurate diagnostic methods and effective treatment regimens for sickle cell disease have been known for many years, and children who receive early diagnosis and subsequent comprehensive care survive well into adulthood-as evidenced by the tremendous success of universal newborn screening programs in North America and Europe.
